BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 37680835)

  • 1. Pakistan National Guidelines for Pediatric High-Grade Gliomas.
    Bashir F; Qureshi BM; Minhas K; Tabori U; Bouffet E; Hawkins C; Enam A; Mushtaq N
    Pak J Med Sci; 2023; 39(5):1548-1554. PubMed ID: 37680835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Durable Response to Nivolumab in a Pediatric Patient with Refractory Glioblastoma and Constitutional Biallelic Mismatch Repair Deficiency.
    AlHarbi M; Ali Mobark N; AlMubarak L; Aljelaify R; AlSaeed M; Almutairi A; Alqubaishi F; Hussain ME; Balbaid AAO; Said Marie A; AlSubaie L; AlShieban S; alTassan N; Ramkissoon SH; Abedalthagafi M
    Oncologist; 2018 Dec; 23(12):1401-1406. PubMed ID: 30104292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High frequency of mismatch repair deficiency among pediatric high grade gliomas in Jordan.
    Amayiri N; Tabori U; Campbell B; Bakry D; Aronson M; Durno C; Rakopoulos P; Malkin D; Qaddoumi I; Musharbash A; Swaidan M; Bouffet E; Hawkins C; Al-Hussaini M;
    Int J Cancer; 2016 Jan; 138(2):380-5. PubMed ID: 26293621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic and therapeutic challenges of glioblastoma as an initial malignancy of constitutional mismatch repair deficiency (CMMRD): two case reports and a literature review.
    Onishi S; Yamasaki F; Kuraoka K; Taguchi A; Takayasu T; Akagi K; Hinoi T
    BMC Med Genomics; 2023 Jan; 16(1):6. PubMed ID: 36647049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Constitutional mismatch repair deficiency (CMMRD) presenting with high-grade glioma, multiple developmental venous anomalies and malformations of cortical development-a multidisciplinary/multicentre approach and neuroimaging clues to clinching the diagnosis.
    Chhabda S; Sudhakar S; Mankad K; Jorgensen M; Carceller F; Jacques TS; Merve A; Aizpurua M; Chalker J; Garimberti E; D'Arco F
    Childs Nerv Syst; 2021 Jul; 37(7):2375-2379. PubMed ID: 33247381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Constitutional mismatch repair deficiency-associated brain tumors: report from the European C4CMMRD consortium.
    Guerrini-Rousseau L; Varlet P; Colas C; Andreiuolo F; Bourdeaut F; Dahan K; Devalck C; Faure-Conter C; Genuardi M; Goldberg Y; Kuhlen M; Moalla S; Opocher E; Perez-Alonso V; Sehested A; Slavc I; Unger S; Wimmer K; Grill J; Brugières L
    Neurooncol Adv; 2019; 1(1):vdz033. PubMed ID: 32642664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic and clinical determinants of constitutional mismatch repair deficiency syndrome: report from the constitutional mismatch repair deficiency consortium.
    Bakry D; Aronson M; Durno C; Rimawi H; Farah R; Alharbi QK; Alharbi M; Shamvil A; Ben-Shachar S; Mistry M; Constantini S; Dvir R; Qaddoumi I; Gallinger S; Lerner-Ellis J; Pollett A; Stephens D; Kelies S; Chao E; Malkin D; Bouffet E; Hawkins C; Tabori U
    Eur J Cancer; 2014 Mar; 50(5):987-96. PubMed ID: 24440087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical screening for mismatch repair protein deficiency in paediatric high-grade gliomas - institutional experience and review of literature.
    Alphones S; Chatterjee U; Singh A; Das A; Zameer L; Achari R; Bhattacharya A; Roy P
    Childs Nerv Syst; 2021 Aug; 37(8):2521-2530. PubMed ID: 34097097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic challenges in a CMMRD patient with a novel mutation in the PMS2 gene: a case report.
    Tan S; Wu X; Wang A; Ying L
    BMC Med Genomics; 2021 Jul; 14(1):184. PubMed ID: 34247610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional Repair Assay for the Diagnosis of Constitutional Mismatch Repair Deficiency From Non-Neoplastic Tissue.
    Shuen AY; Lanni S; Panigrahi GB; Edwards M; Yu L; Campbell BB; Mandel A; Zhang C; Zhukova N; Alharbi M; Bernstein M; Bowers DC; Carroll S; Cole KA; Constantini S; Crooks B; Dvir R; Farah R; Hijiya N; George B; Laetsch TW; Larouche V; Lindhorst S; Luiten RC; Magimairajan V; Mason G; Mason W; Mordechai O; Mushtaq N; Nicholas G; Oren M; Palma L; Pedroza LA; Ramdas J; Samuel D; Wolfe Schneider K; Seeley A; Semotiuk K; Shamvil A; Sumerauer D; Toledano H; Tomboc P; Wierman M; Van Damme A; Lee YY; Zapotocky M; Bouffet E; Durno C; Aronson M; Gallinger S; Foulkes WD; Malkin D; Tabori U; Pearson CE
    J Clin Oncol; 2019 Feb; 37(6):461-470. PubMed ID: 30608896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Constitutional Mismatch Repair Deficiency in Israel: High Proportion of Founder Mutations in MMR Genes and Consanguinity.
    Baris HN; Barnes-Kedar I; Toledano H; Halpern M; Hershkovitz D; Lossos A; Lerer I; Peretz T; Kariv R; Cohen S; Half EE; Magal N; Drasinover V; Wimmer K; Goldberg Y; Bercovich D; Levi Z
    Pediatr Blood Cancer; 2016 Mar; 63(3):418-27. PubMed ID: 26544533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homozygous germ-line mutation of the PMS2 mismatch repair gene: a unique case report of constitutional mismatch repair deficiency (CMMRD).
    Ramchander NC; Ryan NA; Crosbie EJ; Evans DG
    BMC Med Genet; 2017 Apr; 18(1):40. PubMed ID: 28381238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Constitutional mismatch repair deficiency in a healthy child: On the spot diagnosis?
    Suerink M; Potjer TP; Versluijs AB; Ten Broeke SW; Tops CM; Wimmer K; Nielsen M
    Clin Genet; 2018 Jan; 93(1):134-137. PubMed ID: 28503822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis of Constitutional Mismatch Repair-Deficiency Syndrome Based on Microsatellite Instability and Lymphocyte Tolerance to Methylating Agents.
    Bodo S; Colas C; Buhard O; Collura A; Tinat J; Lavoine N; Guilloux A; Chalastanis A; Lafitte P; Coulet F; Buisine MP; Ilencikova D; Ruiz-Ponte C; Kinzel M; Grandjouan S; Brems H; Lejeune S; Blanché H; Wang Q; Caron O; Cabaret O; Svrcek M; Vidaud D; Parfait B; Verloes A; Knappe UJ; Soubrier F; Mortemousque I; Leis A; Auclair-Perrossier J; Frébourg T; Fléjou JF; Entz-Werle N; Leclerc J; Malka D; Cohen-Haguenauer O; Goldberg Y; Gerdes AM; Fedhila F; Mathieu-Dramard M; Hamelin R; Wafaa B; Gauthier-Villars M; Bourdeaut F; Sheridan E; Vasen H; Brugières L; Wimmer K; Muleris M; Duval A;
    Gastroenterology; 2015 Oct; 149(4):1017-29.e3. PubMed ID: 26116798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 10-Year-Old Pakistani Boy With Multiple Malignancies: Loss Of Pms2-Constitutional Mismatch Repair Deficiency.
    Rehman P; Wali RM
    J Ayub Med Coll Abbottabad; 2022; 34(Suppl 1)(3):S727-S729. PubMed ID: 36414603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Challenge of Diagnosing Constitutional Mismatch Repair Deficiency Syndrome in Brain Malignancies from Young Individuals.
    Carrato C; Sanz C; Muñoz-Mármol AM; Blanco I; Pineda M; Del Valle J; Dámaso E; Esteller M; Musulen E
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33924881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic criteria for constitutional mismatch repair deficiency syndrome: suggestions of the European consortium 'care for CMMRD' (C4CMMRD).
    Wimmer K; Kratz CP; Vasen HF; Caron O; Colas C; Entz-Werle N; Gerdes AM; Goldberg Y; Ilencikova D; Muleris M; Duval A; Lavoine N; Ruiz-Ponte C; Slavc I; Burkhardt B; Brugieres L;
    J Med Genet; 2014 Jun; 51(6):355-65. PubMed ID: 24737826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Precision immuno-oncology approach for four malignant tumors in siblings with constitutional mismatch repair deficiency syndrome.
    Palova H; Das A; Pokorna P; Bajciova V; Pavelka Z; Jezova M; Pal K; Dimayacyac JR; Negm L; Stengs L; Bianchi V; Vejmelkova K; Noskova K; Jarosova M; Mejstrikova S; Mudry P; Kyr M; Merta T; Tinka P; Drabova K; Aulicka S; Jugas R; Tabori U; Slaby O; Sterba J
    NPJ Precis Oncol; 2024 May; 8(1):110. PubMed ID: 38773265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence, clinicopathologic, and genetic characteristics of mismatch repair gene-mutated glioblastomas.
    Cho YA; Kim D; Lee B; Shim JH; Suh YL
    J Neurooncol; 2021 May; 153(1):43-53. PubMed ID: 33864561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotherapy holds the key to cancer treatment and prevention in constitutional mismatch repair deficiency (CMMRD) syndrome.
    Westdorp H; Kolders S; Hoogerbrugge N; de Vries IJM; Jongmans MCJ; Schreibelt G
    Cancer Lett; 2017 Sep; 403():159-164. PubMed ID: 28645564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.